FDA grants accelerated approval to new treatment for advanced ovarian cancer – FDA.gov


NBCNews.com

FDA grants accelerated approval to new treatment for advanced ovarian cancer
FDA.gov
The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer. Rubraca is approved for women with advanced ovarian cancer who have been treated with two or more …
FDA Approves Rucaparib for BRCA Ovarian CancerMedscape
PARP Inhibitor Gets FDA Nod for Ovarian CancerMedPage Today
Surprise! Clovis Oncology Nabs Early OKFox Business
GenomeWeb –BioWorld Online –Reuters –New York Times (blog)
all 44 news articles »

View original article
Author:

Powered by WPeMatico